Physician profile
Charles E Stankard
NPI 1043278260
$12,389.98
in general payments reported to CMS, 2019-2025
26 companies · $229 in 2025
The $229 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $118 · 2021: $215 · 2022: $237 · 2023: $375 · 2024: $189 · 2025: $229.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $793.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $793.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $11,237.86 | 2019-2024 | Da Vinci Surgical System |
| Organogenesis INC. | $331.61 | 2020-2025 | Puraply, Puraply Wound Matrix |
| Medtronic, INC. | $151.76 | 2023-2025 | Progrip, Maxtack, Symbotex |
| Smith+Nephew, INC. | $106.03 | 2019-2024 | Grafix Pl, Stravix |
| Davol INC. | $59.04 | 2021-2025 | Phasix Mesh |
| Merck Sharp & Dohme LLC | $58.57 | 2022-2024 | Keytruda, Lynparza |
| Biocomposites INC | $46.87 | 2025 | Stimulan |
| Access Pro Medical, LLC | $39.48 | 2023 | Matriderm |
| Solventum Corporation | $31.27 | 2025 | Activ.A.C., Prevena, V.A.C. Veraflo Cleanse Choice |
| Medela LLC | $30.42 | 2020 | |
| W. L. Gore & Associates, INC. | $29.96 | 2023-2025 | Gore Synecor Biomaterial, Gore Enform Preperitoneal Biomaterial |
| Abbvie INC. | $27.77 | 2025 | |
| Tela Bio, INC. | $27.25 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Baudax Bio INC. | $21.10 | 2021 | |
| Boston Scientific Corporation | $20.40 | 2023 | Spyglass Discover |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aroa Biosurgery Incorporated | $19.35 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.48 | 2025 | Gattex |
| Innocoll Pharmaceuticals Limited | $16.52 | 2022 | |
| Next Science LLC | $16.37 | 2020 | |
| Portola Pharmaceuticals, LLC | $15.61 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $15.10 | 2022 | |
| Allergan, INC. | $15.03 | 2019 | |
| Innovation Technologies INC | $15.00 | 2025 | Irrisept |
| Mimedx Group, INC. | $14.64 | 2024 | |
| Sanara Medtech INC. | $13.09 | 2023 | Celleraterx |
| Amniox Medical, INC. | $12.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Stankard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.